(PDF) Dabigatran Compared With Rivaroxaban vs Warfarin

Dabigatran Compared With Rivaroxaban vs Warfarin

JAMA Internal Medicine - United States

doi 10.1001/jamainternmed.2017.0554

Full Text

Abstract

Available in full text

Categories

Internal Medicine

Date

May 1, 2017

Authors

Janice B. Schwartz

Publisher

American Medical Association (AMA)

Related search

The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland

Value in Health

Occupational Health

English

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Cardiovascular Medicine

Specialized Nursing

English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis

English

The Cost-Effectiveness of Dabigatran Etexilate Compared With Rivaroxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health

Occupational Health

English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology

English

Hospital Length of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared to Warfarin Among Patients With Non-Valvular Atrial Fibrillation?

Value in Health

Occupational Health

English

Pcv51 - Cost Analysis of Safety Outcomes of Dabigatran vs. Warfarin in the Spanish National Health Service

Value in Health

Occupational Health

English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health

Occupational Health

English

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis

English